K Seto
Impact in
- Agronomy and Crop Science top 10%
- Animal Disease Management and Epidemiology
-
- T-cell and Retrovirus Studies
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 2
-
- Organometallic Complex Synthesis and Catalysis 1
- Co-authors
- Takashi Yoshiki (2 shared papers)S Akiyama (3 shared papers)Nobuhisa Ishiguro (2 shared papers)Akemi Wakisaka (2 shared papers)Masatoshi Tateno (1 shared paper)Hiroaki Sakurai (1 shared paper)Hisami Ikeda (1 shared paper)T Togashi (1 shared paper)
In The Last Decade
K Seto
15 papers receiving 346 citations
Peers
Comparison fields: 5 of 73
- Agronomy and Crop Science 88
- Immunology 135
- Periodontics 22
- Oncology 114
- Ecology, Evolution, Behavior and Systematics 75
Countries citing papers authored by K Seto
This map shows the geographic impact of K Seto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Seto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Seto more than expected).
Fields of papers citing papers by K Seto
This network shows the impact of papers produced by K Seto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Seto. The network helps show where K Seto may publish in the future.
Co-authors
The 25 scholars most cited alongside K Seto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 103 | |
| 2 | 1997 | 64 | |
| 3 | 2005 | 52 | |
| 4 | Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. | 1990 | 43 |
| 5 | 1995 | 21 | |
| 6 | Effect of a dihydropyridine analogue, 2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo- 1,3,2-dioxaphosphorinan-2-yl)-1-(2-morpholinoethyl)-4-(3-nitrophenyl)-3 -pyridinecarboxylate on reversing in vivo resistance of tumor cells to adriamycin. | 1992 | 17 |
| 7 | 2008 | 17 | |
| 8 | 1992 | 14 | |
| 9 | 1992 | 9 | |
| 10 | [Two cases of angiomyoma of the palatal region]. | 1978 | 3 |
| 11 | 1999 | 3 | |
| 12 | [Double cancers of the oral region: a case report and a survey of subject literature]. | 1979 | 2 |
| 13 | 1992 | 2 | |
| 14 | Changes in airway space following mandibular setback using sagittal split osteotomy and rigid internal fixation. | 1997 | 2 |
| 15 | [A compound odontoma associated with a deciduous tooth]. | 1986 | 2 |
| 16 | 2006 | 0 |
About K Seto
K Seto is a scholar working on Oncology, Organic Chemistry, Pathology and Forensic Medicine, Immunology and Oral Surgery, having authored 16 papers that have together received 354 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (2 papers), T-cell and Retrovirus Studies (2 papers), Oral and Maxillofacial Pathology (2 papers), Oral Health Pathology and Treatment (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Soft tissue tumor case studies (1 paper), Organometallic Complex Synthesis and Catalysis (1 paper) and Autoimmune Bullous Skin Diseases (1 paper). The work is most often cited by research in Agronomy and Crop Science (88 citations), Immunology (135 citations), Periodontics (22 citations), Oncology (114 citations) and Ecology, Evolution, Behavior and Systematics (75 citations). K Seto has collaborated with scholars based in Japan, Canada and Russia. Frequent co-authors include Takashi Yoshiki, S Akiyama, Nobuhisa Ishiguro, Akemi Wakisaka, Masatoshi Tateno, Hiroaki Sakurai, Hisami Ikeda, T Togashi, Midori Abe and Tomoyuki Sumizawa. Their work appears in journals such as Oral Diseases, Chemical and Pharmaceutical Bulletin, Acta Neuropathologica, The Journal of Experimental Medicine and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.